Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia-Reference-Cited by-同舟云学术

Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia

Published:2020-11-28 Issue:2 Volume:81 Page:233-256
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Zhanel George G.^ORCID,Deng Christina,Zelenitsky Sheryl,Lawrence Courtney K.,Adam Heather J.,Golden Alyssa,Berry Liam,Schweizer Frank,Zhanel Michael A.,Irfan Neal,Bay Denice,Lagacé-Wiens Philippe,Walkty Andrew,Mandell Lionel,Lynch Joseph P.,Karlowsky James A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-020-01443-4.pdf

Reference84 articles.

1. Dillon C, Guarascio AJ, Covvey JR. Lefamulin: a promising new pleuromutilin antibiotic in the pipeline. Expert Rev Anti Infect Ther. 2019;17(1):5–15.

2. Lee YR, Jacobs KL. Leave it to lefamulin: a pleuromutilin treatment option in community-acquired bacterial pneumonia. Drugs. 2019;79(17):1867–76.

3. Medical Association A. Lefamulin (Xenleta) for community-acquired bacterial pneumonia. Med Lett Drugs Ther. 2019;61(1581):145–8.

4. Paukner S, Riedl R. Pleuromutilins: potent drugs for resistant bugs-mode of action and resistance. Cold Spring Harb Perspect Med. 2017;7(1):1–15.

5. Novak R. Are pleuromutilin antibiotics finally fit for human use? Ann N Y Acad Sci. 2011;1241:71–81.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive compounds of forest fungi for diverse biotechnological applications;Forest Fungi;2025

2. Mechanism of staphylococcal resistance to clinically relevant antibiotics;Drug Resistance Updates;2024-11

3. Treatment of MRSA Infection: Where are We?;Current Medicinal Chemistry;2024-08

4. Semisynthesis: An Essential Tool for Antibiotics Drug Discovery;ChemistrySelect;2024-06-18

5. In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice;International Journal of Molecular Sciences;2024-05-15